Home Infusion Licensing: The Trap Between “Pharmacy” and “DME” Accreditations

Answer Summary:

Home Infusion providers face a unique “Regulatory Split” in 2026. While CMS requires a specific “Home Infusion Therapy” accreditation to bill for services (Nursing), the drugs themselves fall under State Board of Pharmacy rules, and the pumps often fall under DME licensure. Failing to align these three distinct “Permission Pillars” is the primary cause of payment recoupments.

Introduction:

Home Infusion is one of the fastest-growing sectors in healthcare, but it is also the most legally confused.

Are you a Pharmacy? Are you a DME? Are you a Nursing Agency?

The answer is: Yes, Yes, and Yes.

And that is the problem. You need a license for each identity. In 2026, we are seeing a wave of audits targeting providers who have the “Pharmacy” license but lack the “DME” license for the pump itself.

The “Three-Legged Stool” of Compliance

To bill a single Home Infusion claim correctly, you often need three different permissions:

1. The Drug (J-Codes)

• Regulation: State Board of Pharmacy.
• Requirement: A Pharmacy License (and Non-Resident Pharmacy permits for shipping across state lines).

2. The Pump (E-Codes)

• Regulation: DMEPOS (Medicare) and State DME Boards.
• Requirement: A DME Retailer License.
• The Trap: Many pharmacies assume their Pharmacy license covers the pump. In many states (like Florida or California), it does not. You need a separate DME permit.

3. The Service (G-Codes)

• Regulation: CMS Part B.
• Requirement: “Home Infusion Therapy (HIT)” Accreditation. This is separate from your pharmacy or DME accreditation. It specifically covers the nursing/training aspect.

The “Unlicensed Activity” Audit

What happens if you miss one leg of the stool?

• Scenario: You ship an IV antibiotic (Drug) and an infusion pump (DME) to a patient. You have a Pharmacy license but no DME license.
• The Audit: The payer pays for the drug but recoups the payment for the pump equipment, citing unlicensed activity.
• The Fine: State Boards can issue fines of $1,000+ per day for operating an unlicensed DME facility.

Useful Resources

• CMS Home Infusion Therapy (HIT) Monitoring: Official CMS guidance on the new benefit category HIT Monitoring Reports
• National Home Infusion Association (NHIA): State-by-state regulatory maps NHIA Legislative Maps

WWS Value Proposition:

We Map the Overlap

Home Infusion credentialing is 3x harder than standard DME. Wonder Worth Solutions specializes in this “Regulatory Split.” We manage your Pharmacy Board licenses, your DME licenses, and your HIT Accreditation simultaneously. We ensure the “Three-Legged Stool” never wobbles.